Opioid Solutions for the Digital Age
New On Demand Dr. Nick: The Incrementalist: With guest Gus Crothers, MD, Chief Medical Officer, at Groups Recover Together who have focused on solving the Opioid Use Disorder.
Read MoreNew On Demand Dr. Nick: The Incrementalist: With guest Gus Crothers, MD, Chief Medical Officer, at Groups Recover Together who have focused on solving the Opioid Use Disorder.
Read MoreNew On Demand Healthcare Upside/Down: With guest Gary Frazier, Founder and CEO of Worksite Labs. He joins Dr. Nick to talk about a reimagined laboratory business and the advantages of keeping healthcare local.
New On Demand Dr. Nick: The Incrementalist: With guest Zachary Green, a U.S. Marine Corps veteran and former Firefighter, author of ‘Warrior Entrepreneur’ book who has had an interesting career and some major events and adversity that he has had to overcome.
New On Demand Healthcare Upside/Down with guest Greg Bellomy, CEO of Care ATC. He joins Dr. Nick to discuss why shooting for the moon in healthcare starts with going back to basics.
New On Demand Dr. Nick: The Incrementalist: With guest Jennifer Meller, MD, CEO & Founder of Navimize, that is focusing on solving the problem of dissatisfaction for patients stuck in waiting rooms around the country.
New On Demand Healthcare Upside/Down: With guest Pramod John, CEO of Vivio Health. He joins Dr. Nick to discuss why we need to ask the right questions about our healthcare system, rethink many of our assumptions, and examine the ways that economic incentives influence care decisions.
New On Demand Dr. Nick: The Incrementalist: With guests Morgane Mouslim, PhD a Policy analyst at the Hilltop Institute at the University of Maryland Baltimore County and Morgan Henderson, PhD, a Data Scientist at the Hilltop Institute at the University of Maryland Baltimore County.
New On Demand Healthcare Upside/Down: With guest AJ Loiacono, CEO of CapitalRx, an organization dedicated to disrupting the pharmacy benefit manager marketplace. He joins Dr. Nick to discuss the reasons why drug prices are so exorbitant—and he’s hopeful that change is on the horizon.